Sexually Transmitted Diseases (STD) Testing Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : December 2019 Pages : 172 Category: Medical Devices Report Code : HC127622
Sexually Transmitted Diseases (STD) Testing Market by Type (Gonorrhea Testing, HIV Testing, HPV Testing, Chlamydia Testing, Syphilis Testing, HSV Testing, Chancroid Testing) Application (Hospitals, Clinics) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Sexually Transmitted Diseases (STD) Testing Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Sexually Transmitted Diseases (STD) Testing is useful in detecting any kind of Sexually Transmitted virus. Sexually transmitted diseases are known to be one of the most critical health challenges globally. Chlamydia, gonorrhea, and herpes simplex virus are some of the highly prevalent sexually transmitted diseases.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- F. Hoffmann La Roche
- Qiagen
- BioMerieux
- BD
- Bio-Rad Laboratories
- Abbott
- Alere
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Sexually Transmitted Diseases (STD) Testing Market , By Type, Estimates and Forecast, 2017-2027 ($Million)
o Gonorrhea Testing, HIV Testing
o HPV Testing
o Chlamydia Testing
o Syphilis Testing
o HSV Testing
o Chancroid Testing
· Sexually Transmitted Diseases (STD) Testing Market , By Application, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Clinics
· Sexually Transmitted Diseases (STD) Testing Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o F. Hoffmann La Roche
o Qiagen
o BioMerieux
o BD
o Bio-Rad Laboratories
o Abbott
o Alere
· Sexually Transmitted Diseases (STD) Testing Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Sexually Transmitted Diseases (STD) Testing Market , By Country
o U.S. Sexually Transmitted Diseases (STD) Testing Market
o Canada Sexually Transmitted Diseases (STD) Testing Market
o Mexico Sexually Transmitted Diseases (STD) Testing Market
o Europe
§ Europe Sexually Transmitted Diseases (STD) Testing Market , By Country
· Germany Sexually Transmitted Diseases (STD) Testing Market
o UK Sexually Transmitted Diseases (STD) Testing Market
o France Sexually Transmitted Diseases (STD) Testing Market
o Russia Sexually Transmitted Diseases (STD) Testing Market
o Italy Sexually Transmitted Diseases (STD) Testing Market
o Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
o Asia-Pacific
§ Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market , By Country
o China Sexually Transmitted Diseases (STD) Testing Market
o Japan Sexually Transmitted Diseases (STD) Testing Market
o South Korea Sexually Transmitted Diseases (STD) Testing Market
o India Sexually Transmitted Diseases (STD) Testing Market
o Southeast Asia Sexually Transmitted Diseases (STD) Testing Market
o Rest of Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market
o South America
§ South America Sexually Transmitted Diseases (STD) Testing Market
o Brazil Sexually Transmitted Diseases (STD) Testing Market
o Argentina Sexually Transmitted Diseases (STD) Testing Market
o Columbia Sexually Transmitted Diseases (STD) Testing Market
o Rest of South America Sexually Transmitted Diseases (STD) Testing Market
o Middle East and Africa
§ Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market
o Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market
o UAE Sexually Transmitted Diseases (STD) Testing Market
o Egypt Sexually Transmitted Diseases (STD) Testing Market
o Nigeria Sexually Transmitted Diseases (STD) Testing Market
o South Africa Sexually Transmitted Diseases (STD) Testing Market
o Rest of MEA Sexually Transmitted Diseases (STD) Testing Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Sexually Transmitted Diseases (STD) Testing Market, By Type
5.1. Introduction
5.2. Global Sexually Transmitted Diseases (STD) Testing Revenue and Market Share by Type (2017-2027)
5.2.1. Global Sexually Transmitted Diseases (STD) Testing Revenue and Revenue Share by Type (2017-2027)
5.3. Gonorrhea Testing
5.3.1. Global Gonorrhea Testing Revenue and Growth Rate (2017-2027)
5.4. HIV Testing
5.4.1. Global HIV Testing Revenue and Growth Rate (2017-2027)
5.5. HPV Testing
5.5.1. Global HPV Testing Revenue and Growth Rate (2017-2027)
5.6. Chlamydia Testing
5.6.1. Global Chlamydia Testing Revenue and Growth Rate (2017-2027)
5.7. Syphilis Testing
5.7.1. Global Syphilis Testing Revenue and Growth Rate (2017-2027)
5.8. HSV Testing
5.8.1. Global HSV Testing Revenue and Growth Rate (2017-2027)
5.9. Chancroid Testing
5.9.1. Global Chancroid Testing Revenue and Growth Rate (2017-2027)
6. Sexually Transmitted Diseases (STD) Testing Market, By Application
6.1. Introduction
6.2. Global Sexually Transmitted Diseases (STD) Testing Revenue and Market Share by Application (2017-2027)
6.2.1. Global Sexually Transmitted Diseases (STD) Testing Revenue and Revenue Share by Application (2017-2027)
6.3. Hospitals
6.3.1. Global Hospitals Revenue and Growth Rate (2017-2027)
6.4. Clinics
6.4.1. Global Clinics Revenue and Growth Rate (2017-2027)
7. Sexually Transmitted Diseases (STD) Testing Market, By Region
7.1. Introduction
7.2. Global Sexually Transmitted Diseases (STD) Testing Revenue and Market Share by Regions
7.2.1. Global Sexually Transmitted Diseases (STD) Testing Revenue by Regions (2017-2027)
7.3. North America Sexually Transmitted Diseases (STD) Testing by Countries
7.3.1. North America Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2027)
7.3.2. North America Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Sexually Transmitted Diseases (STD) Testing by Countries
7.4.1. Europe Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2027)
7.4.2. Europe Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Sexually Transmitted Diseases (STD) Testing by Countries
7.5.1. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Sexually Transmitted Diseases (STD) Testing by Countries
7.6.1. South America Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2027)
7.6.2. South America Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Sexually Transmitted Diseases (STD) Testing by Countries
7.7.1. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. F. Hoffmann La Roche
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Qiagen
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. BioMerieux
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. BD
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bio-Rad Laboratories
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Abbott
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Alere
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
9. Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.1. Global Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Sexually Transmitted Diseases (STD) Testing Market Forecast by Regions (2017-2027)
9.2.1. North America Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.1.1. United States Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.1.2. Canada Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.1.3. Mexico Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.2. Europe Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.2.1. Germany Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.2.2. France Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.2.3. UK Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.2.4. Russia Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.2.5. Italy Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.3. Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.3.1. China Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.3.2. Japan Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.3.3. Korea Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.3.4. India Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.4. South America Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.4.1. Brazil Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.4.2. Argentina Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.4.3. Columbia Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.4.4. Rest of South America Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.5. Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.5.3. Egypt Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.5.4. Nigeria Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.5.5. South Africa Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.5.6. Turkey Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Forecast (2017-2027)
9.3. Sexually Transmitted Diseases (STD) Testing Market Forecast by Type (2017-2027)
9.3.1. Sexually Transmitted Diseases (STD) Testing Forecast by Type (2017-2027)
9.3.2. Sexually Transmitted Diseases (STD) Testing Market Share Forecast by Type (2017-2027)
9.4. Sexually Transmitted Diseases (STD) Testing Market Forecast by Application (2017-2027)
9.4.1. Sexually Transmitted Diseases (STD) Testing Forecast by Application (2017-2027)
9.4.2. Sexually Transmitted Diseases (STD) Testing Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Sexually Transmitted Diseases (STD) Testing Revenue and Revenue Share by Type (2017-2018)
Figure Global Gonorrhea Testing Revenue and Growth Rate (2017-2018)
Figure Global HIV Testing Revenue and Growth Rate (2017-2018)
Figure Global HPV Testing Revenue and Growth Rate (2017-2018)
Figure Global Chlamydia Testing Revenue and Growth Rate (2017-2018)
Figure Global Syphilis Testing Revenue and Growth Rate (2017-2018)
Figure Global HSV Testing Revenue and Growth Rate (2017-2018)
Figure Global Chancroid Testing Revenue and Growth Rate (2017-2018)
Table Global Sexually Transmitted Diseases (STD) Testing Revenue and Revenue Share by Application (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Table Global Sexually Transmitted Diseases (STD) Testing Revenue by Regions (2017-2018)
Figure North America Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure North America Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2018)
Figure North America Sexually Transmitted Diseases (STD) Testing by Countries (2017-2018)
Figure North America Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2018)
Figure United States Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure United States Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Canada Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Mexico Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Europe Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2018)
Figure Europe Sexually Transmitted Diseases (STD) Testing by Countries (2017-2018)
Figure Europe Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2018)
Figure Germany Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Germany Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure France Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure UK Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Russia Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Italy Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Rest of Europe Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Sexually Transmitted Diseases (STD) Testing by Countries (2017-2018)
Figure Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2018)
Figure China Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure China Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Japan Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Korea Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure India Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Southeast Asia Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure South America Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2018)
Figure South America Sexually Transmitted Diseases (STD) Testing by Countries (2017-2018)
Figure South America Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Brazil Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Argentina Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Columbia Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Rest of South America Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Sexually Transmitted Diseases (STD) Testing by Countries (2017-2018)
Figure Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Saudi Arabia Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure United Arab Emirates Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Egypt Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Nigeria Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure South Africa Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Turkey Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Sexually Transmitted Diseases (STD) Testing Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2017-2018)
Table F. Hoffmann La Roche Sexually Transmitted Diseases (STD) Testing Financial Overview
Table Qiagen Sexually Transmitted Diseases (STD) Testing Financial Overview
Table BioMerieux Sexually Transmitted Diseases (STD) Testing Financial Overview
Table BD Sexually Transmitted Diseases (STD) Testing Financial Overview
Table Bio-Rad Laboratories Sexually Transmitted Diseases (STD) Testing Financial Overview
Table Abbott Sexually Transmitted Diseases (STD) Testing Financial Overview
Table Alere Sexually Transmitted Diseases (STD) Testing Financial Overview
Figure Global Sexually Transmitted Diseases (STD) Testing Revenue (Millions USD) and Growth Rate (2018-2025)
Table Sexually Transmitted Diseases (STD) Testing Market Forecast by Regions (2018-2025)
Figure North America Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure United States Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Canada Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Mexico Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Europe Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Germany Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure France Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure UK Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Russia Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Italy Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Rest of Europe Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure China Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Japan Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Korea Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure India Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Southeast Asia Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure South America Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Brazil Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Argentina Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Columbia Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Rest of South America Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Saudi Arabia Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure United Arab Emirates Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Egypt Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Nigeria Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure South Africa Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Turkey Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Sexually Transmitted Diseases (STD) Testing Market Forecast (2018-2025)
Figure Global Sexually Transmitted Diseases (STD) Testing Forecast by Type (2018-2025)
Figure Global Sexually Transmitted Diseases (STD) Testing Market Share Forecast by Type (2018-2025)
Figure Global Sexually Transmitted Diseases (STD) Testing Forecast by Type (2018-2025)
Figure Global Sexually Transmitted Diseases (STD) Testing Forecast by Application (2018-2025)
Figure Global Sexually Transmitted Diseases (STD) Testing Market Share Forecast by Application (2018-2025)
Figure Global Sexually Transmitted Diseases (STD) Testing Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|